GB Sciences, Inc. Announces the First GrowBLOX(TM) Cultivation Chamber Has Been Shipped to Las Vegas

LAS VEGAS, July 29, 2014 (GLOBE NEWSWIRE) -- GrowBLOX Sciences, Inc. (GBLX) a medical marijuana research and development company, announced that the first GrowBLOX(TM) cultivation chamber has been shipped and is expected to land in Las Vegas, Nevada, within just a few days. The timing is perfect as The Company continues to receive high interest in their cultivation science and technology. For example, The Company recently announced a binding Memorandum of Understanding with LaurelCo, LLC (Chicago, Illinois) in which GB Sciences, Inc. licensed the use of their proprietary GrowBLOXTM growing chambers in exchange for a 20% equity interest. The MOU also included licenses for additional proprietary technologies, collectively termed "GrowBLOXTMSolutions", required for tissue culture, growing chambers, curing technology, proprietary extraction processes and creation of "GBLX"-branded, pharmaceutical-grade medical marijuana products.

The GrowBLOX(TM) chamber was specifically designed to produce optimal environmental growing conditions for medical cannabis cultivation. Each chamber is equipped with the latest energy-efficient technological advancements in both lighting and hydroponic technologies—all controlled by a revolutionary intelligent control system. The GrowBLOX(TM) chamber is the first to provide real time monitoring and control of the growth process in order to consistently produce high-grade medicinal marijuana. The GrowBLOX(TM) hydroponic technology allows for continuous, healthy cycles of cannabis plants that will reach optimized medicinal potency during the bloom cycle. Each fully enclosed chamber physically isolates each plant to protect from the onset and spread of insect and mite infestations in the grow operation and to keep harmful contaminants, such as pesticides, insecticides, and vehicle exhaust out of the medicinal plants growing inside.

CEO Craig Ellins said, "Receiving the first GrowBLOX(TM) cultivation chamber is an important milestone in the history of our company. As The Company continues to pursue and develop partnerships in states with approved medical marijuana legislation, we will strongly leverage our cutting-edge cultivation technology."

About GrowBLOX Sciences, Inc.

GrowBLOX Sciences, Inc., is a research and biotechnical company that has developed proprietary indoor growing chambers specifically designed for medical cannabis cultivation. The GrowBLOX chamber allows for completely controlled growing conditions, ensuring the manufacture of a consistent, toxin-free, natural and medicinal-grade product. The Company believes that the advantages of a controlled environment over traditional outdoor or greenhouse growing, will empower the public, nutraceutical and pharmaceutical industries to embrace cannabis as an effective treatment for a myriad of serious medical conditions.

Forward-Looking Statements

Except for historical information contained herein, the statements in this release are forward-looking and made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are inherently unreliable and actual results may differ materially. Examples of forward-looking statements in this news release include statements regarding the payment of dividends, marketing and distribution plans, development activities and anticipated operating results. Factors which could cause actual results to differ materially from these forward-looking statements include such factors as the Company's ability to accomplish its business initiatives, significant fluctuations in marketing expenses and ability to achieve and expand significant levels of revenues, or recognize net income, from the sale of its products and services, as well as the introduction of competing products, or management's ability to attract and maintain qualified personnel necessary for the development and commercialization of its planned products, and other information that may be detailed from time to time in the Company's filings with the United States Securities and Exchange Commission. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.




Jonathan Barkman
Riverview Capital Enterprises